Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report
- 6 August 2020
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 136 (6), 763-766
- https://doi.org/10.1182/blood.2020006854
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML surveyLeukemia, 2020
- Philadelphia‐positive acute lymphoblastic leukaemia (ALL) in Italy during the COVID‐19 pandemic: a Campus ALL studyBritish Journal of Haematology, 2020
- The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patientsBlood, 2020
- COVID-19 in persons with chronic myeloid leukaemiaLeukemia, 2020
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020Published by Harborside Press, LLC ,2020
- Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatmentAmerican Journal of Hematology, 2019